Eptinezumab (CALCA /CALCB) - Research Grade Biosimilar
Product Specifications
Background
Eptinezumab is a fully-humanized IgG1 antibody manufactured using yeast (Pichia pastoris) and developed by Lundbeck Seattle Biopharmaceuticals.7 Eptinezumab has been specifically designed to bind to both alpha and beta forms of the human calcitonin gene-related peptide (CGRP) .8,1,2,3 It was approved by the FDA in February 2020 for the preventive treatment of migraine headaches in adults.
Immunogen
Humanized / CALCA /CALCB [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
ALD-403
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940266-500 1x 500 µL
Human IgG Immunoglobulin (IG266), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471073-100 1x 100 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940906-500 1x 500 µL
Cytokeratin 7 (KRT7/760 + KRT7/903), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400904-500 1x 500 µL
CD34 (QBEnd/10 + HPCA1/763), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details